Mirroring the increased potency in organoids, P-Rspo3 mice showed clear intestinal lesions at 2 weeks that progressed to widespread hyperplastic and dysplastic adenomas by 5 weeks (Fig. 4a). Here, RSPO3 is linked to adenoma.